← back to search

Qing Liu

Mongolian University of Science and Technology · CN
Area of research
Otorhinolaryngology · Surgery
Research interest
Research interests include Head and Neck Cancer Studies, Head and Neck Surgical Oncology, Esophageal Cancer Research and Treatment, and Lung Cancer Treatments and Mutations.
h-index
29
citations
3,532
works
218
NIH funding
primary concept
Medicine
email

Recent publications

Nrf2 alleviates acute ischemic stroke induced ferroptosis via regulating xCT/GPX4 pathway
Free Radical Biology and Medicine 2025cited by 30position: middledoi
Expert consensus on the prevention and treatment of radiochemotherapy-induced oral mucositis
International Journal of Oral Science 2025cited by 19position: middledoi
Naoqing formula alleviates cerebral ischemia/reperfusion injury induced inflammatory injury by regulating Csf3 mediated JAK/STAT pathway and macrophage polarization
Phytomedicine 2025cited by 9position: middledoi
Alcohol exposure alters the diversity and composition of oral microbiome
Frontiers in Cellular and Infection Microbiology 2025cited by 3position: lastdoi
Efficacy of Laser Therapy for Grade C Periodontitis in Young Individuals
International Journal of Medical Sciences 2025cited by 2position: lastdoi
Effects of Chinese Medicine on modulating interleukin-17-regulated macrophages in coronary heart disease
Frontiers in Pharmacology 2025cited by 0position: middledoi
Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial
The Lancet Oncology 2024cited by 49position: middledoi
Residual ciprofloxacin in chicken manure inhibits methane production in an anaerobic digestion system
Poultry Science 2024cited by 5position: middledoi
Effect of chronic alcohol consumption on oral microbiota in rats with periodontitis
PeerJ 2024cited by 4position: lastdoi
Image Steganography Scheme Based on 3D Chaotic Sequence and Prediction Error
2024cited by 4position: middledoi
Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
The Lancet 2023cited by 102position: middledoi
Gefitinib Plus Chemotherapy vs Gefitinib Alone in Untreated <i>EGFR</i>-Mutant Non–Small Cell Lung Cancer in Patients With Brain Metastases
JAMA Network Open 2023cited by 51position: middledoi
Concurrent chemoradiotherapy followed by adjuvant cisplatin–gemcitabine versus cisplatin–fluorouracil chemotherapy for N2–3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial
The Lancet Oncology 2023cited by 39position: middledoi
Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial
European Journal of Cancer 2023cited by 29position: middledoi
Intraoperative radiotherapy in recurrent IDH-wildtype glioblastoma with gross total resection: A single-center retrospective study
Clinical Neurology and Neurosurgery 2023cited by 3position: middledoi
Evaluation of the safety and efficacy of a Polyzene-F nanocoated coronary stent system: A systematic review and single-arm meta-analysis
Frontiers in Cardiovascular Medicine 2023cited by 0position: lastdoi
Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma
JAMA 2022cited by 172position: middledoi
Phase I study of adjuvant immunotherapy with autologous tumor-infiltrating lymphocytes in locally advanced cervical cancer
Journal of Clinical Investigation 2022cited by 54position: middledoi
Effectiveness of Sequential Chemoradiation vs Concurrent Chemoradiation or Radiation Alone in Adjuvant Treatment After Hysterectomy for Cervical Cancer
JAMA Oncology 2021cited by 128position: middledoi
Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal Carcinoma
JAMA Oncology 2020cited by 248position: middledoi
Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
Journal of Clinical Oncology 2020cited by 208position: middledoi
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial
European Journal of Cancer 2019cited by 220position: middledoi
Comparison of Neoadjuvant Chemoradiotherapy and Neoadjuvant Chemotherapy for Esophageal Cancer: A Meta-Analysis
Future Oncology 2019cited by 29position: middledoi
Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer (AEROC): a phase 2, single-arm, prospective study
The Lancet Oncology 2018cited by 217position: middledoi
Clinical complete response after chemoradiotherapy for carcinoma of thoracic esophagus: Is esophagectomy always necessary? A systematic review and meta‐analysis
Thoracic Cancer 2018cited by 33position: middledoi
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial
European Journal of Cancer 2017cited by 283position: middledoi
Clinical Activity of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Post-Mastectomy Triple-Negative Breast Cancer
Clinical Cancer Research 2014cited by 87position: middledoi
Locoregional radiotherapy in patients with distant metastases of nasopharyngeal carcinoma at diagnosis
Chinese Journal of Cancer 2013cited by 131position: middledoi
HER2-positive patients receiving trastuzumab treatment have a comparable prognosis with HER2-negative advanced gastric cancer patients: A prospective cohort observation
International Journal of Cancer 2013cited by 65position: middledoi
Concurrent chemoradiotherapy for esophageal squamous cell carcinoma: a meta-analysis
Zhonghua fangshe zhongliuxue zazhi 2013cited by 0position: middledoi

Grants

Collaborative Research: Elements: ProDM: Developing A Unified Progressive Data Management Library for Exascale Computational Science
NSF2311757$179,4712023–2026PIRePORTER
CAREER: Enabling Progressive Data Analytics for High Performance Computing: Algorithms and System Support
NSF2144403$499,7482022–2027PIRePORTER
Collaborative Research: SHF: Small: Rethinking Performance Variation for Emerging Applications - An Application-centric and Cross-layer Approach
NSF2134202$189,9542022–2026PIRePORTER
SHF:Small: Collaborative Research: Understanding, Modeling, and System Support for HPC Data Reduction
NSF1812861$259,0242018–2023PIRePORTER
SHF:Small: Collaborative Research: Tailoring Memory Systems for Data-Intensive HPC Applications
NSF1718297$147,9982017–2021PIRePORTER
STTR Phase I: A novel biomimetic nanofiber coating on dental implants for gingival regeneration
NSF1346430$225,0002014–2014PIRePORTER
Current-Injection Disk Nanolasers
NSF1102109$349,2042011–2014PIRePORTER
ITR: A Novel Framework with Fast Inverse Scattering Algorithms for Future Environmental Sensing
NSF0219528$297,0002002–2006PIRePORTER
Fast Algorithms for Wave Scattering in Layered Media for Electronic Packaging and Geophysical Exploration
NSF0098140$267,0002001–2005PIRePORTER
CAREER: Efficient Numerical Solutions in Geophysical Subsurface Sensing
NSF9996412$145,1951999–2001PIRePORTER
CAREER: Efficient Numerical Solutions in Geophysical Subsurface Sensing
NSF9702195$200,0001997–1999PIRePORTER

Frequent collaborators

Min Zheng · Guangzhou University of Chinese Medicine4 papers (2018–2022)Jun‐Dong Li · Sun Yat-sen University3 papers (2018–2022)Na Liu · Beijing University of Chinese Medicine3 papers (2024–2025)Xinping Cao · Tianjin Medical University3 papers (2020–2022)Xin Huang · Central South University3 papers (2018–2021)Shaowu Jing · Hebei Medical University3 papers (2013–2019)Yunjie Cheng · Hebei Medical University3 papers (2013–2019)Chunyan Lan · Nanchang University2 papers (2018–2020)Weijun Ye · Sun Yat-sen University2 papers (2021–2022)Wanqing Zhao · Hebei Medical University2 papers (2024–2025)Xin Xie · Jiangsu University2 papers (2025–2025)Jia He · Service de Santé des Armées2 papers (2014–2022)He Huang · Zhejiang Chinese Medical University2 papers (2021–2022)Feng Cao · Anhui Medical University2 papers (2013–2018)Jun Wang · Hebei Medical University2 papers (2018–2019)Ling Guo · Wannan Medical College2 papers (2013–2023)Ting Wan · Yunnan University2 papers (2021–2022)Yiming Bi · Guangzhou University of Chinese Medicine2 papers (2025–2025)Yi Wang · Anhui University of Traditional Chinese Medicine2 papers (2013–2018)Jihong Liu · Sun Yat-sen University2 papers (2021–2022)